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LETTERS TO THE EDITOR
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tRegarding “Outcomes of percutaneous endovascular
intervention for type II endoleak with aneurysm
expansion”
I read with much interest the article “Outcomes of percutaneous
endovascular intervention for type II endoleak with aneurysm expan-
sion,” which appeared in the May issue of the Journal.1 I would like to
point out that the authors have wrongly specified our technique as a
post-endovascular aneurysm repair (EVAR) operative approach.2
Our technique is a preventive technique performed during
EVAR and not a post-EVAR operative approach. As we wrote in
two other articles,3,4 natural history and our experience in the
treatment of type II endoleaks led us to investigate prevention as
the best strategy in managing this complication.
Intrasac biomaterial insertion stimulates clot formation excluding
the aortic collateral branches and stabilizing the entire complex en
bloc. This technique is quick and safe, regardless of the stent graft
used. In our experience, it is effective in significantly reducing the
incidence of type II endoleak even in follow-up beyond 1 year.5
Salvatore Ronsivalle, MD
Vascular and Endovascular Surgery and Angiology
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Regarding “Inferior vena cava resection and
reconstruction for retroperitoneal tumor excision”
The authors report their surgical experience of inferior vena cava
(IVC) resection and reconstruction for patients with retroperitoneal
tumor excision.1 Of the 47 patients included in the study, 27 patients
underwent circumferential resection of the IVC and replacement with
polytetrafluoroethylene (PTFE) graft after en bloc tumor resection.
Eighteen of these patients underwent extensive resection and replace-
ment of the IVC. We would like to commend the authors for their
excellent surgical technique and the postoperative results.
We have encountered similar situations in the management of
patients with advanced renal cell cancer extending into the IVC.2 To
resect the entire tumor, excision of the affected portion of the IVC was
required in several instances.3,4 A significant proportion of these
patients presented with complete obstruction of the IVC with tumor
thrombus. From our practice, it may not be necessary to reconstruct
the IVC in patients with complete obstruction with established col-
lateralization. A natural venovenous bypass evolves from the collateral
c
o
1198eins created by the obstruction of the IVC.5 We have previously
eported on a total of nine patients who had complete obstruction of
he IVC and underwent IVC resection without reconstruction.3,4 In
ost of our cases, IVC clamping above and below the tumor throm-
us did not result in systemic hypotension due to adequate natural
ollateralization. The major concerns of interrupting the IVC are
orbidity associated with venous congestion and lymphatic extrava-
ation causing third space retention. Generally, in patients with
hronic occlusion of the IVC without evidence of preoperative lower
xtremity edema, these complications are well tolerated. The benefits
f not reconstructing the IVC are noteworthy and include reductions
n operative time, avoidance of graft infections, and potential lifelong
nticoagulation.6
Finally, the authors have described their approach for replace-
ent of the retrohepatic IVC with the outflow control below and
bove the liver.1 In patients with renal cell carcinoma, we have
ncountered similar situations where the thrombus invades to the
oint of the retrohepatic IVC. We have obtained vascular control
f the retrohepatic segment of the IVC using the “piggyback” liver
obilization technique, which eliminates the need of hepatic
ascular isolation.1,2,4 Mobilization of the IVC from the abdomi-
al wall is a key step for the IVC reconstruction. This technique
ay be selectively utilized in retrohepatic IVC replacements.2
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Important issues are raised in your letter. Our report of 47
atients with retroperitoneal tumors, the majority of which were
arcomas, undergoing radical resection with vena cava reconstruc-
ion specifically excluded patients with renal cell carcinoma.1 Renal
ell carcinomas with involvement of the inferior vena cava most
ften can be resected with limited inferior vena cava excision and
